A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures
Public ClinicalTrials.gov record NCT01964560. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label, Long-term Extension Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Pediatric Subjects With Epilepsy With Partial-Onset Seizures
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of lacosamide (LCM) in pediatric subjects.
Study identification
- NCT ID
- NCT01964560
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 540 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 1 Month to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 13, 2014 (Actual)
- Primary completion
- Apr 13, 2022 (Actual)
- Completion
- Apr 13, 2022 (Actual)
- Last update posted
- Oct 25, 2022
2014 – 2022
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ep0034 638 | Birmingham | Alabama | 35233-1711 | — |
| Ep0034 105 | Orlando | Florida | 32819 | — |
| Ep0034 117 | Tampa | Florida | 33609 | — |
| Ep0034 124 | Lexington | Kentucky | 40536-0284 | — |
| Ep0034 115 | Henderson | Nevada | 89052 | — |
| Ep0034 120 | Lebanon | New Hampshire | 03756 | — |
| Ep0034 102 | Charlotte | North Carolina | 28203 | — |
| Ep0034 640 | Springfield | Oregon | 97477 | — |
| Ep0034 129 | Dallas | Texas | 75235 | — |
| Ep0034 630 | San Antonio | Texas | 78207 | — |
| Ep0034 114 | Seattle | Washington | 98105-0371 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 130 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01964560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01964560 live on ClinicalTrials.gov.